JHBP CY Holdings Ltd - ESG Rating & Company Profile powered by AI
Other corporations in the rating industry group for JHBP CY Holdings Ltd are displayedin the table. The analysis of JHBP CY Holdings Ltd employs intelligence from across the internet as well as from available disclosures by JHBP CY Holdings Ltd. If you work at JHBP CY Holdings Ltd and you would like to licence your Sustainability aseessment, please get in touch.
JHBP CY Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.4; made up of an environmental score of 4.0, social score of 1.6 and governance score of 1.6.
2.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1499 | Verici Dx Plc | 2.5 | Medium |
| 1499 | Verve Therapeutics Inc | 2.5 | Medium |
| 1512 | JHBP CY Holdings Ltd | 2.4 | Medium |
| 1512 | CEL-SCI Corp | 2.4 | Medium |
| 1512 | Allena Pharmaceuticals Inc | 2.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does JHBP CY Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes JHBP CY Holdings Ltd report the average age of the workforce?
Sign up for free to unlockDoes JHBP CY Holdings Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes JHBP CY Holdings Ltd offer flexible work?
Sign up for free to unlockDoes JHBP CY Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes JHBP CY Holdings Ltd conduct supply chain audits?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes JHBP CY Holdings Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose water use targets?
Sign up for free to unlockDoes JHBP CY Holdings Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid JHBP CY Holdings Ltd have a product recall in the last two years?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes JHBP CY Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas JHBP CY Holdings Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose parental leave metrics?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes JHBP CY Holdings Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes JHBP CY Holdings Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs JHBP CY Holdings Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose its waste policy?
Sign up for free to unlockDoes JHBP CY Holdings Ltd report according to TCFD requirements?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose energy use targets?
Sign up for free to unlockDoes JHBP CY Holdings Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes JHBP CY Holdings Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for JHBP CY Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
JHBP (CY) Holdings Limited, a biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally. The company's principal drug candidates include GB491 (lerociclib), an oral CDK4/6 inhibitor for treating hormone receptor-positive (HR+)/HER2- breast cancer; GB221, a herceptin (trastuzumab)-mimic HER2 monoclonal antibody (mAb) drug candidate; geptanolimab (GB226), a novel PD-1 mAb drug candidate; GB492, a stimulator of interferon genes (STING) agonist expected to exert synergistic effects in combination with GB226 for solid tumors; GB242, an infliximab (Remicade) biosimilar; and GB223, a receptor activator of nuclear factor-B Ligand (RANKL) mAb drug candidate. JHBP (CY) Holdings Limited was founded in 2007 and is headquartered in Shanghai, China.